Molina Healthcare (MOH)

The sleeper story is Medicare duals quietly crushing it at 90.7% MCR while everyone fixates on the Medicaid rate/trend imbalance; this $5B business just added $1.50 to guidance and management admits they'll hit target margins 'sooner than originally expected.' The obvious marketplace disaster ($1.50 guidance cut) actually reveals something worse: MOH kept members on $1,000/month drug therapies that don't generate risk adjustment revenue, proving they fundamentally misunderstood their risk pool. The binding constraint isn't Medicaid rates, it's that MOH needs states to acknowledge 20% medical cost inflation over 3 years to restore margins. Most revealing quote: 'We underestimated the amount of stickiness on these high-cost members that don't have commensurate HCC codes.' My view changes if Q3 shows marketplace MCR above 92% or Medicaid trend accelerates beyond 5%.